Navigate Ongoing COVID-19 Vaccine Changes
You’ll need to stay on top of changing COVID-19 vaccine guidance...now that monovalent mRNA products are no longer authorized.
Only about 17% of people in the US have had a bivalent dose.
Acknowledge that overall vaccine efficacy wanes over time and most patients have had COVID-19...making data challenging to interpret.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote